Patents by Inventor Svend Treppendahl

Svend Treppendahl has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190167667
    Abstract: Liquid formulations of lactic acid addition salts of 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine are provided.
    Type: Application
    Filed: June 27, 2018
    Publication date: June 6, 2019
    Inventors: Svend Treppendahl, Heidi Lopez de Diego
  • Patent number: 10034876
    Abstract: Liquid formulations of lactic acid addition salts of 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine are provided.
    Type: Grant
    Filed: September 21, 2016
    Date of Patent: July 31, 2018
    Assignee: H. Lundbeck A/S
    Inventors: Svend Treppendahl, Heidi Lopez de Diego
  • Publication number: 20170224677
    Abstract: Liquid formulations of lactic acid addition salts of 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine are provided.
    Type: Application
    Filed: September 21, 2016
    Publication date: August 10, 2017
    Inventors: Svend Treppendahl, Heidi Lopez de Diego
  • Patent number: 9475748
    Abstract: Liquid formulations of lactic acid addition salts of 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine are provided.
    Type: Grant
    Filed: December 11, 2014
    Date of Patent: October 25, 2016
    Assignee: H. Lundbeck A/S
    Inventors: Svend Treppendahl, Heidi Lopez De Diego
  • Patent number: 9382205
    Abstract: Disclosed herein are processes for the preparation of a pharmaceutically active agent and pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: November 25, 2014
    Date of Patent: July 5, 2016
    Assignee: H. Lundbeck A/S
    Inventors: Frans Therkelsen, Michael Harold Rock, Svend Treppendahl
  • Publication number: 20150094316
    Abstract: Liquid formulations of lactic acid addition salts of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine are provided
    Type: Application
    Filed: December 11, 2014
    Publication date: April 2, 2015
    Inventors: Svend Treppendahl, Heidi Lopez De Diego
  • Publication number: 20150080584
    Abstract: Disclosed herein are processes for the preparation of a pharmaceutically active agent and pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: November 25, 2014
    Publication date: March 19, 2015
    Inventors: Frans Therkelsen, Michael Harold Rock, Svend Treppendahl
  • Patent number: 8940746
    Abstract: Liquid formulations of lactic acid addition salts of 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piper-azine are provided.
    Type: Grant
    Filed: April 16, 2010
    Date of Patent: January 27, 2015
    Assignee: H. Lundbeck A/S
    Inventors: Svend Treppendahl, Heidi Lopez De Diego
  • Patent number: 8901318
    Abstract: Disclosed herein are processes for the preparation of a pharmaceutically active agent and pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: May 2, 2013
    Date of Patent: December 2, 2014
    Assignee: H. Lundbeck A/S
    Inventors: Frans Therkelsen, Michael Harold Rock, Svend Treppendahl
  • Publication number: 20130245281
    Abstract: Disclosed herein are processes for the preparation of a pharmaceutically active agent and pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: May 2, 2013
    Publication date: September 19, 2013
    Applicant: H. Lundbeck A/S
    Inventors: Frans Therkelsen, Michael Harold Rock, Svend Treppendahl
  • Patent number: 8501947
    Abstract: The present invention relates to a process for the manufacture of 4-((1R,3S)-6-Chloro-3-phenyl-indan-1-yl)-1,2,2-trimethyl-piperazine or a pharmaceutically acceptable salt thereof and a process for the manufacture of 1-((1R,3S)-6-Chloro-3-phenyl-indan-1-yl)-3,3-dimethyl-piperazine or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: July 7, 2010
    Date of Patent: August 6, 2013
    Assignee: H. Lundbeck A/S
    Inventors: Svend Treppendahl, Allan Carsten Dahl
  • Patent number: 8461353
    Abstract: Disclosed herein are processes for the preparation of a pharmaceutically active agent and pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: December 20, 2010
    Date of Patent: June 11, 2013
    Assignee: H. Lundbeck A/S
    Inventors: Frans Therkelsen, Michael Harold Rock, Svend Treppendahl
  • Publication number: 20120165325
    Abstract: Polymorphic forms of N-(2,6-dimethyl-4-morpholin-4-yl-phenyl)-3,3-dimethyl-butyramide are provided together with a process for the manufacture of said compound.
    Type: Application
    Filed: March 2, 2012
    Publication date: June 28, 2012
    Applicant: H. Lundbeck A/S
    Inventors: Svend Treppendahl, Karin Liltorp, Heidi Lopez de Diego
  • Publication number: 20120142923
    Abstract: The present invention relates to a process for the manufacture of 4-((1R,3S)-6-Chloro-3-phenyl-indan-1-yl)-1,2,2-trimethyl-piperazine or a pharmaceutically acceptable salt thereof and a process for the manufacture of 1-((1R,3S)-6-Chloro-3-phenyl-indan-1-yl)-3,3-dimethyl-piperazine or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: July 7, 2010
    Publication date: June 7, 2012
    Applicant: H. LUNDBECK A/S
    Inventors: Svend Treppendahl, Allan Carsten Dahl
  • Publication number: 20120035188
    Abstract: Liquid formulations of lactic acid addition salts of 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine are provided.
    Type: Application
    Filed: April 16, 2010
    Publication date: February 9, 2012
    Applicant: H. LUNDBECK A/S
    Inventors: Svend Treppendahl, Heidi Lopez De Diego
  • Publication number: 20110152539
    Abstract: Disclosed herein are processes for the preparation of a pharmaceutically active agent and pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: December 20, 2010
    Publication date: June 23, 2011
    Applicant: H. LUNDBECK A/S
    Inventors: Frans Therkelsen, Michael Harold Rock, Svend Treppendahl
  • Publication number: 20100286138
    Abstract: Polymorphic forms of N-(2,6-dimethyl-4-morpholin-4-yl-phenyl)-3,3-dimethyl-butyramide are provided together with a process for the manufacture of said compound.
    Type: Application
    Filed: May 11, 2010
    Publication date: November 11, 2010
    Applicant: H. LUNDBECK A/S
    Inventors: Svend Treppendahl, Karin Liltorp, Heidi Lopez de Diego
  • Patent number: 6613791
    Abstract: N-substituted azaheterocycyclic carboxylic acids and esters thereof of the formula I wherein Z, X, R1, R2 and r are defined in the specification. Compositions thereof and methods for preparing the compounds are disclosed. The compounds are useful for clinical treatment of painful, hyperalgesic and/or inflammatory conditions in which C-fibers play a pathophysiological role by eliciting neurogenic pain or inflammations.
    Type: Grant
    Filed: August 17, 2000
    Date of Patent: September 2, 2003
    Assignee: Novo Nordisk A/S
    Inventors: Florenzio Zaragossa Dörwald, Enud Erik Andersen, Rolf Hohlweg, Peter Madsen, Tine Krogh Jørgensen, Uffe Bang Olsen, Henrik Sune Andersen, Svend Treppendahl, Polivka Zdenék, Silhánková Alexandra, Sindelár Karel
  • Patent number: 6569849
    Abstract: The present invention relates to novel N-substituted azaheterocyclic compounds of the general formula wherein X, Y, Z, A, R1, R2, r and s are as defined in the detailed part of the present description or salts thereof, to methods for their preparation, to compositions containing them, and to their use for the clinical treatment of painful, hyperalgesic and/or inflammatory conditions in which C-fibers play a pathophysiological role by eliciting neurogenic pain or inflammation as well as their use for treatment of indications caused by or related to secretion and circulation of insulin antagonising peptides.
    Type: Grant
    Filed: October 3, 1997
    Date of Patent: May 27, 2003
    Assignee: Novo Nordisk A/S
    Inventors: Tine Krogh Jorgensen, Rolf Hohlweg, Peter Madsen, Knud Erik Andersen, Svend Treppendahl, Uffe Bang Olsen, Zdenek Polivka, Alexandra Silhankova, Karel Sindelar, Vladimir Valenta, Tomas Kalisz
  • Patent number: 6372776
    Abstract: The present invention provides novel crystalline (−)-3R,4R-trans-7-methoxy-2,2-dimethyl-3-phenyl-4-{4-[2-(pyrrolidin-1-yl)ethoxy]phenyl}chromane, hydrogen maleate useful for reducing or preventing bone loss as well as pharmaceutical compositions containing the same. A process for preparing (−)-3R,4R-trans-7-methoxy-2,2-dimethyl-3-phenyl-4-{4-[2-(pyrrolidin-1-yl)ethoxy]phenyl}chromane, hydrogen maleate is described.
    Type: Grant
    Filed: June 8, 1998
    Date of Patent: April 16, 2002
    Assignee: Novo Nordisk A/S
    Inventors: Svend Treppendahl, Klaus Snej Jensen, Scott Eugene McGraw